Chimeric antigen receptor T cell therapy can be administered safely under the real-time monitoring of Th1/Th2 cytokine pattern using the cytometric bead array technology for relapsed and refractory acute lymphoblastic leukemia in children

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

T Cell Therapy ◽

Th2 Cytokine ◽

Cytokine Pattern ◽

Array Technology ◽

Leukemia In Children

The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor–T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma

Cytotherapy ◽

10.1016/j.jcyt.2020.01.015 ◽

2020 ◽

Vol 22 (4) ◽

pp. 214-226 ◽

Cited By ~ 3

Author(s):

Jun-Xia Cao ◽

Hui Wang ◽

Wei-Jian Gao ◽

Jia You ◽

Li-Hua Wu ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

T Cell Therapy

Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia

The Cancer Journal ◽

10.1097/ppo.0000000000000508 ◽

2021 ◽

Vol 27 (2) ◽

pp. 98-106

Author(s):

Jordan Gauthier ◽

Cameron J. Turtle

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Cell Acute Lymphoblastic Leukemia

KTE-C19 (anti-CD19 chimeric antigen receptor [CAR] T cell therapy) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL): Preliminary Results of ZUMA-4

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.07.013 ◽

2017 ◽

Vol 17 ◽

pp. S252-S253 ◽

Cited By ~ 1

Author(s):

Daniel W. Lee ◽

Alan Wayne ◽

Van Huynh ◽

Rupert Handgretinger ◽

Rob Pieters ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

T Cell Therapy ◽

Preliminary Results ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T

Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Acute Lymphoblastic Leukemia (B-ALL)

10.1007/978-3-030-78311-2_11 ◽

2021 ◽

pp. 179-196

Author(s):

Geoffrey Shouse ◽

Elizabeth Budde ◽

Stephen Forman

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T

Abstract 1630: FLT3 chimeric antigen receptor T cell therapy induces B to T cell lineage switch in infant acute lymphoblastic leukemia

10.1158/1538-7445.am2018-1630 ◽

2018 ◽

Cited By ~ 1

Author(s):

Christopher D. Chien ◽

Lila Yang ◽

Sang M. Nguyen ◽

Christopher T. Sauter ◽

Kazusa Ishii ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Infant Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia ◽

Cell Lineage ◽

Antigen Receptor ◽

T Cell Therapy ◽

Lineage Switch ◽

Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia

Medicine ◽

10.1097/md.0000000000025786 ◽

2021 ◽

Vol 100 (19) ◽

pp. e25786

Author(s):

Fu Ming Zi ◽

Long Long Ye ◽

Ji Fu Zheng ◽

Jing Cheng ◽

Qing Ming Wang

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Jak Inhibitor ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

T Cell Therapy

Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia

Current Treatment Options in Oncology ◽

10.1007/s11864-020-0706-6 ◽

2020 ◽

Vol 21 (2) ◽

Cited By ~ 5

Author(s):

Talha Badar ◽

Nirav N. Shah

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy

Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22 T Cell Therapy in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

SSRN Electronic Journal ◽

10.2139/ssrn.3421605 ◽

2019 ◽

Author(s):

Hanren Dai ◽

Zhiqiang Wu ◽

Hejin Jia ◽

Chuan Tong ◽

Yelei Guo ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Receptor Targeting ◽

T Cell Therapy ◽

Cell Acute Lymphoblastic Leukemia

Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.7002 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 7002-7002 ◽

Cited By ~ 25

Author(s):

Noelle V. Frey ◽

Pamela A Shaw ◽

Elizabeth O. Hexner ◽

Saar Gill ◽

Katherine Marcucci ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T

Outcomes of patients (pts) treated with prior blinatumomab (Blin) in ZUMA-3: A study of KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) t cell therapy, in adult pts with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.7006 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7006-7006 ◽

Cited By ~ 4

Author(s):

Bijal D. Shah ◽

Olalekan O. Oluwole ◽

Maria R. Baer ◽

Michael Russell Bishop ◽

Houston Eccleston Holmes ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T